Patents Examined by Philip C Edwards
-
Patent number: 12285617Abstract: Embodiments describe herein generally pertain to implantable medical device (IMDs), and methods for use therewith, that can be used to automatically switch an IMD from its normal operational mode to magnetic resonance imaging (MRI) safe mode, and vice versa, within increased specificity. A controller of an IMD is configured to use an accelerometer to determine whether a positional condition associated with a patient is detected, and control sampling of a magnetic field sensor or at least one signal output therefrom, such that a first sampling rate is used when the positional condition is detected, and a second sampling rate, that is slower than the first sampling rate, is used when the positional condition is not detected, to thereby conserve power. Based on results of the sampling, the controller determines whether a magnetic field condition is detected, and in response thereto performs a mode switch to an MRI safe mode.Type: GrantFiled: July 18, 2022Date of Patent: April 29, 2025Assignee: Pacesetter, Inc.Inventors: Xing Pei, Brad Lindevig, Stuart Rosenberg, Nima Badie
-
Patent number: 12279852Abstract: A physiological monitor switches between a time domain analysis and a frequency domain analysis for determining a heart rate based on objective indicia of signal quality in an acquired heart rate signal.Type: GrantFiled: February 7, 2023Date of Patent: April 22, 2025Assignee: Whoop, Inc.Inventors: William Ahmed, John Vincenzo Capodilupo, Aurelian Nicolae
-
Patent number: 12251559Abstract: A fixation mechanism of an implantable medical device is formed by a plurality of tines fixedly mounted around a perimeter of a distal end of the device. Each tine may be said to include a first segment fixedly attached to the device, a second segment extending from the first segment, and a third segment, to which the second segment extends. When the device is loaded in a lumen of a delivery tool and a rounded free distal end of each tine engages a sidewall that defines the lumen, to hold the tines in a spring-loaded condition, the first segment of each tine, which has a spring-biased pre-formed curvature, becomes relatively straightened, and the third segment of each tine, which is terminated by the free distal end, extends away from the axis of the device at an acute angle in a range from about 45 degrees to about 75 degrees.Type: GrantFiled: May 3, 2021Date of Patent: March 18, 2025Assignee: Medtronic, Inc.Inventors: Xin Chen, Michael D. Eggen, Vladimir Grubac, Brian P. Colin, Wei Gan, Thomas A. Anderson, Kathryn Hilpisch
-
Patent number: 12232800Abstract: Embodiments of medical treatment including skin treatment using electrical energy, especially with the primary purpose for skin treatment for aesthetics are described generally herein. Other embodiments may be described and claimed.Type: GrantFiled: May 31, 2024Date of Patent: February 25, 2025Assignee: Serendia, LLCInventor: Jongju Na
-
Patent number: 12226646Abstract: In embodiments, a Wearable Cardiac Defibrillator (WCD) system is configured to be worn by an ambulatory patient. The WCD system includes a main user interface (UI) output device that can output an image, sound or vibration as a main message about a condition of the patient or the WCD system. The patient may further carry a peripheral device that can also output an image, sound or vibration as a peripheral message about the condition. The peripheral message may mirror the main message at least in part, amplify it, and so on. The availability of the peripheral message provides the patient with the opportunity to better perceive the main message, and the flexibility to receive and react to it discreetly, learn more about the condition, and so on.Type: GrantFiled: June 17, 2021Date of Patent: February 18, 2025Assignee: West Affum Holdings DACInventors: Zoie Engman, Aaron Piazza, Christoffer Peter Hart Hansen, David P. Finch, Laura M. Gustavson, Erik L. Schneider, Erick Roane, Amanda K. Hall
-
Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
Patent number: 12220579Abstract: Disclosed are apparatuses and methods for reducing or limiting blood loss and reducing bleed time in a subject by combined vagus and trigeminal stimulation. The apparatuses and methods may activate (e.g., electrically) one or more branches of the trigeminal nerve and may concurrently (at overlapping or near-overlapping time) independently activate the vagus nerve. This activation may be invasive or non-invasive.Type: GrantFiled: January 18, 2022Date of Patent: February 11, 2025Assignee: The Feinstein Institutes for Medical ResearchInventor: Kirk R. Manogue -
Patent number: 12220577Abstract: A device for the transcutaneous electrical stimulation of the trigeminal nerve is provided. The device has an elongated symmetrical support with at least one electrode pair, and the support can be applied on a person's forehead in the supraorbital region to cover the afferent paths of the supratrochlear and supraorbital nerves of the ophthalmic branch of the trigeminal nerve. Each electrode pair contacts a self-adhesive conductive gel that at least partially covers one surface of the support for attaching the support to the forehead to be applied to two lateral zones with the exception of an insulating central zone. Each lateral zone has one electrode of the electrode pair, an electric circuit for supplying to the electrode pair electric pulses that have a predefined intensity, and a measurement means for measuring the intensity of the supplied pulses that is connected to the electric circuit.Type: GrantFiled: July 1, 2021Date of Patent: February 11, 2025Assignee: Cefaly Technology SPRLInventors: Pierre-Yves Muller, Pierre Rigaux
-
Patent number: 12213795Abstract: Systems and methods for remote therapy and patient monitoring are provided. A method comprises contacting an outer skin surface of a patient with a contact surface of a stimulator and transmitting an electrical impulse from the stimulator transcutaneously through the outer skin surface to a nerve within the patient. Data related to parameters of the electrical impulse applied to the nerve is stored and transmitted to a remote source. The data may include duration of treatment, amplitude of the electrical impulse, compliance with a prescribed therapy regimen or other relevant data related to the therapy. The method may further include collecting patient status data, such as symptoms of a medical condition (e.g., severity of a headache) before, during and/or after stimulation. The patient status data is correlated with the treatment data to monitor compliance and/or the effectiveness of the therapy.Type: GrantFiled: November 13, 2023Date of Patent: February 4, 2025Inventors: Bruce J. Simon, Joseph P. Errico
-
Patent number: 12208268Abstract: An electrical stimulation system includes a control module that provides electrical stimulation signals to an electrical stimulation lead coupled to the control module for stimulation of patient tissue. The system also includes a sensor to be disposed on or within the body of the patient and to measure a biosignal; and a processor to communicate with the sensor to receive the biosignal and to generate an adjustment to one or more of the stimulation parameters based on the biosignal. The adjustment can be configured and arranged to steer the electrical stimulation signals to stimulate a region of the patient tissue that is different, at least in part, from a region of the patient tissue stimulated prior to the adjustment. Alternatively or additionally, the biosignal is indicative of a particular patient activity and the adjustment is a pre-determined adjustment selected for the particular patient activity.Type: GrantFiled: November 10, 2021Date of Patent: January 28, 2025Assignee: Boston Scientific Neuromodulation CorporationInventors: Michael A. Moffitt, Sridhar Kothandaraman
-
Patent number: 12201820Abstract: A medical device system includes a cardiac electrical stimulation device and a ventricular assist device (VAD). The cardiac stimulation device and the VAD are capable of communication with each other to confirm detection of cardiac events.Type: GrantFiled: December 3, 2021Date of Patent: January 21, 2025Assignee: Medtronic, Inc.Inventor: Mark L. Brown
-
Patent number: 12194302Abstract: A neuromodulation system and method with feedback optimized electrical field generation for stimulating target tissue of a patient to treat neurological and non-neurological conditions. The system generally includes implantable electrodes, implantable sensors, an implantable or external electrical signal generator, and an implantable or external controller. The controller controls the electrical signal generator to generate electrical noise stimulation signals that are delivered to the target tissue via the electrodes and that produce an optimized electric field having maximized voltage with low current density. The sensors produce temperature and impedance data for the target tissue and the controller automatically responds to values of the sensor data that indicate potential damage to the target tissue to reduce the strength of the electric field.Type: GrantFiled: July 19, 2021Date of Patent: January 14, 2025Assignee: Soin Neuroscience, LLCInventor: Amol N. Soin
-
Patent number: 12186547Abstract: Systems and methods for treating a patient having symptoms of restless legs syndrome (RLS) or Periodic Limb Movement Disorder (PLMD) using high-frequency stimulation by applying a high-frequency pulsed electrostimulation therapy signal to a peroneal nerve or a branch thereof, where the therapy signal is above a motor threshold of a muscle innervated by the peroneal nerve or branch thereof. Surface EMG (sEMG) response to neurostimulation can be used to evaluate patient responsivity to neurostimulation, or to evaluate neurostimulation efficacy, such as to compare various neurostimulation parameter settings and to select between such settings to meet or balance between one or more goals. The sEMG response can be obtained with the muscle at rest, or during muscle activation.Type: GrantFiled: July 30, 2021Date of Patent: January 7, 2025Assignee: NOCTRIX HEALTH, INC.Inventors: Jonathan David Charlesworth, Shriram Raghunathan
-
Patent number: 12171996Abstract: A customized electrical stimulation providing system includes: an electrical stimulation request input unit receiving electrical stimulation mode selection information; an electrical stimulation control unit setting an electrical stimulation control variable according to the electrical stimulation mode selection information and generating a control signal; and an electrical stimulation providing means receiving the control signal generated by the electrical stimulation control unit and providing electrical stimulation, wherein the electrical stimulation mode selection information includes at least one of a beauty mode (muscle loss mode) and a muscle strengthening mode.Type: GrantFiled: July 30, 2021Date of Patent: December 24, 2024Assignee: DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGYInventors: Min Seok Kim, Min Young Kim, Hyun Young Shin
-
Patent number: 12168134Abstract: A method of locating an implantation site in the brain includes inserting a plurality of multi-contact electrodes into a region of a target structure in an individual's brain. High Frequency Stimulation (HFS) is applied to a contact of a multi-contact electrode of the plurality of multi-contact electrodes. High Frequency Oscillations (HFO) evoked in the region of the target structure by the HFS are measured. Evoked Compound Activity (ECA) evoked in the region of the target structure by the HFS is measured. It is determined if at least one of the HFO and the ECA is above a predetermined threshold. If at least one of the HFO and the ECA is above the predetermined threshold, a location of the contact of the multi-contact electrode is identified as a site for electrode implantation in the individual's brain.Type: GrantFiled: August 12, 2021Date of Patent: December 17, 2024Assignee: UNIVERSITY OF HOUSTON SYSTEMInventors: Nuri F. Ince, Musa Ozturk, Ashwin Viswanathan
-
Patent number: 12157001Abstract: A system and method for providing therapy to a patient can include a monitoring unit and a therapy unit. The monitoring unit can have a user interface and one or more sensors to measure patient data. The therapy unit can have a stimulator for generating electrical stimulation and a microcontroller for controlling the generation of the electrical stimulation based on the measured patient data.Type: GrantFiled: September 4, 2020Date of Patent: December 3, 2024Assignee: Cala Health, Inc.Inventors: Serena HanYing Wong, Kathryn H. Rosenbluth, Samuel Richard Hamner, Paula Jean Chidester, Scott Lee Delp, Terence D. Sanger
-
Patent number: 12144986Abstract: Disclosed is a system including a good comprising a sensor in contact with human tissues of a patient and configured to obtain a power dissipation reading of the human tissues. The good also includes a storage medium for tangibly storing thereon a program for execution by a processor. The system also includes a control unit in communication with the good to form an electrical muscular stimulation (EMS) system that uses feedback in a closed loop manner to self tune electrical properties of the output. The control unit is configured to instruct the sensor to (a) apply a sense pulse to the human tissues, (b) measure power dissipation of the sense pulse, (c) adjust a stimulation pulse based on the measured power dissipation, (d) apply the stimulation pulse to the human tissues based on the power dissipation and based on the program in order to maintain constant power output across each pulse, and (e) repeat steps (a)-(d).Type: GrantFiled: April 9, 2021Date of Patent: November 19, 2024Assignee: MOTIVE HEALTH, INC.Inventors: Struan Coleman, Calvin Domenico, Edison Gieswein
-
Patent number: 12138468Abstract: Methods and systems that analyze electrocardiogram (ECG) data to identify whether it would be beneficial for a caregiver to administer an electric shock to the heart in an effort to get the heart back into a normal pattern and a consistent, strong beat. By conducting a running check for conditions that are pre-validated by a comprehensive patient database to have high predictive value (e.g., with a low false-positive rate), a shockable rhythm can be identified fast (e.g., less than 6 seconds, less than 3 seconds, possibly in less than a second) and without having to analyze ECG data for longer time segments than would otherwise be required using conventional methods.Type: GrantFiled: February 26, 2021Date of Patent: November 12, 2024Assignee: ZOLL Medical CorporationInventors: Naveed Zaidi, Frederick J. Geheb, Qing Tan, Gary A. Freeman
-
Patent number: 12121734Abstract: Implantable medical devices have a feedthrough from the device to the outside world to pass electrical current from electronics inside the implant to the patient or vice versa. A plurality of sensors and/or signal wires in a wire bundle must connect to the feedthrough and implant in living tissue in the patient. Chemical and physical forces work against the wire connections on the feedthrough. Disclosed embodiments include a biocompatible housing that can be used for an implantable medical device. The biocompatible housing includes a recess with at least one wire exit port, the recess having at least one feedthrough assembly mounted therein. A wire of the feedthrough assembly passes out the wire exit port, and the recess has a top hermetically sealed over it.Type: GrantFiled: October 18, 2021Date of Patent: October 22, 2024Assignee: WYSS CENTER FOR BIO AND NEURO ENGINEERINGInventors: Dana D. Tompkins, Christopher D. Gongora, Achim Kitschmann, Jennifer Losasso-Tompkins, Claude Clément
-
Patent number: 12121719Abstract: A neuromodulator includes an electromagnetic (EM) wave generator configured to generate EM waves remote from a patient and to direct the EM waves to one or more target regions within the patient. Frequencies of the EM waves fall outside a range of frequencies that activates neurons. Intersection of the EM waves in each target region creates envelope-modulated electric and magnetic fields having one or more frequencies that fall within the range of frequencies that activates neurons. The neuromodulator includes control circuitry configured to control parameters of the EM waves produced by the EM wave generator. The neuromodulator may use feedback based on one or more of patient input and/or sensing of physiological signals in order to close the loop and control the EM waves.Type: GrantFiled: September 21, 2021Date of Patent: October 22, 2024Assignee: Xerox CorporationInventor: Krishnan Thyagarajan
-
Patent number: 12115365Abstract: An unattended approach can increase the reproducibility and safety of the treatment as the chance of over/under treating of a certain area is significantly decreased. On the other hand, unattended treatment of uneven or rugged areas can be challenging in terms of maintaining proper distance or contact with the treated tissue, mostly on areas which tend to differ from patient to patient (e.g. facial area). Delivering energy via a system of active elements embedded in a flexible pad adhesively attached to the skin offers a possible solution. The unattended approach may include delivering of multiple energies to enhance a visual appearance.Type: GrantFiled: February 12, 2024Date of Patent: October 15, 2024Assignee: BTL Healthcare Technologies A.S.Inventors: Tomás Schwarz, Lucia Jelínková, Vojtech Kubík